Observational studyJournal of diabetes investigation2019

Effect of switching to teneligliptin from other dipeptidyl peptidase-4 inhibitors on glucose control and renoprotection in type 2 diabetes patients with diabetic kidney disease.

Munehiro Kitada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.